Advanced Medical Isotope Corp. (OTCMKTS: ADMD) is having an incredibly strong start to the trading session this morning and for good reason. The company announced positive clinical data, leading to excitement among investors and sending the stock toward the top. Of course, our partners at Trade Ideas were the first to alert us to the gains. Currently (11:10), ADMD is trading at $0.078 per share after a gain of $0.009 per share or 13.04% thus far today.
ADMD Runs Toward The Top On Positive Results
As mentioned above, Advanced Medical Isotope is having an incredibly strong start to the trading session this morning after the company announced positive clinical results. The results came from the initial study of RadioGelTM at Washington State University.
During the study, researchers at WSU treated two cats for feline sarcoma using RadioGel. Through their PR, ADMD said that RadioGel performed as designed and that the study confirmed objective response, which is measured by destruction of tumor tissue, without any negative or detrimental side-effects. In a statement, Dr. Mike Korenko, CEO at ADMD, had the following to offer…
“We are thrilled to see confirmation of RadioGel’s potential… The clinical research team at WSU safely achieved near-uniform placement of RadioGel under ultrasound guidance using the same parallel injection technique that will also be used to treat human skin cancer tumors.”
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will be keeping a close eye on ADMD. In particular, we’re going to be following the ongoing work surrounding RadioGel and we’re excited to follow the performance of the treatment. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!